在患有N2非小细胞肺癌的患者中,不同术后放射治疗技术的有效性:元分析
Binxi Yao1, Haoxiang Zhang2, Xi Liang1
1Department of Radiotherapy, Hebei Province Hospital of Chinese Medicine, Hebei University of Chinese Medicine Shijiazhuang 050011, Hebei, China.
American journal of translational research
|December 16, 2024
概括
使用3D符合或强度调节技术的术后放射治疗 (PORT) 改善了存活率,并减少了N2非小细胞肺癌的复发. 传统的放射治疗PORT减少了复发,但没有显著的整体存活率.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 胸部外科手术 胸部外科手术
背景情况:
- 累积的临床试验调查了N2非小细胞肺癌 (NSCLC) 的术后放射治疗 (PORT) 的现代精确放射治疗技术.
- 进行了更新的元分析,以评估这些技术的有效性.
研究的目的:
- 评估术后放射治疗 (PORT) 与非PORT对N2型NSCLC患者整体生存期 (OS) 和局部区域复发 (LR) 的影响.
- 为了在PORT设置中比较传统放射治疗,3D-符合放射治疗 (3D-CRT) 和强度调节放射治疗 (IMRT) 的有效性.
主要方法:
- 一个全面的文献搜索确定了相关的研究.
- 对33项涉及PORT组的8653名患者和非PORT组的12398名患者的研究的元分析.
- 分析了OS和LR的95%置信区间 (CI) 的危险比率 (HR) 和相对风险 (RR).
主要成果:
- 波特显示了OS的显著改善 (HR:0.95,P:0.0009) 和LR的显著减少 (RR:0.56,P<0.00001).
- IMRT (HR: 0.77,P: 0.003) 和3D-CRT (HR: 0.82,P: 0.002) 显示了显著的OS益处.
- 传统的放射治疗,3D-CRT和IMRT都显著降低了LR (所有人的RR<0.61).
结论:
- 使用3D-CRT或IMRT的术后放射治疗对N2 NSCLC患者在LR和OS方面提供了显著的好处.
- 虽然传统的放射治疗PORT显著减少了LR,但它没有产生统计学上显著的OS增加.
相关概念视频
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Radiological Investigation III: Pulmonary Angiogram and PET Scan
84
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
84


